This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Nano Labs Report To Shareholders

Stocks in this article: CTLE

DETROIT, April 26, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE) is pleased to provide the following update to shareholders highlighting our progress and our vision for the year 2013.

Dear Shareholders,

We continue to follow our core strategy of developing a diversified investment of nanotechnologies for our shareholders in Nano Labs.

Our core strategy is founded on four main ideals: first, identify and prioritize the obvious problems that we face in the world today; second, to concentrate our resources on developing our proprietary nano technology to evolve common products into new, revolutionary products in order to solve these problems; third, to leverage our international business contacts and networks to introduce these novel solutions to existing problems; and fourth, to work with strategic partners on commercializing these high-value solutions being brought to market in a timely fashion. We're confident that we will continue to create value for our shareholders by executing this core strategy.

Our teams of scientists, designers, and engineers remain focused on creating a portfolio of advanced products that will provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. We are continuing to create products in these industries to provide us the ability to generate revenues from different market sectors, and our hard work we believe is close to yielding significant results.

We have had many exciting highlights this year to date and I would like to take a moment and share my insights on these with you.

Strong Partnerships

Our important partnerships are a testament to our core strategy. Most notably, we are extremely pleased with the advances in our partnership with CIATEQ. They have proven to be a key cornerstone in our company development. We have made exciting progress in creating solutions, prototypes and testing of several new products in the nano medicine, antiviral and pharma applications that we are excited to reveal in the near future. Testing products takes time, but every day we get closer. The upcoming quarter will be an exciting one. Of note, our marketing team has posted a CIATEQ video which is featured on the home page of our website, and I invite you to view it. Currently, we employ four full time employees at the CIATEQ facilities in Queretaro and twenty-one post grad employees under the direction of Dr. Castano working at CIATEQ and our universities facilities.

1 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs